Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Neurology·MeSH: Spastic ataxia Charlevoix-Saguenay type
Prevalence
75.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay?
There are 2 clinical trials targeting Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay tracked by BioSniper.
What is the prevalence of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay?
The estimated prevalence of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay is approximately 75.0 per 100,000 population.
Deep-dive into Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis